MAPT and Alzheimer disease: According to our results, there will be a point in the AD continuum when sTREM2 reaches its highest levels later but its elevations are no longer associated with attenuation in phosphorylated tau, suggesting that pro-inflammatory microglial cells are not protective against the disease pathological changes until late AD.